Dude, you jumped on a thread, on a company I have never...

Dude, you jumped on a thread, on a company I have never discussed with you. Made a massive generalised and incorrect swipe about my overall Hot Copper participation, without the faintest idea, and in that dismissed the often high appraisal of analysis I get as pump - in fact one of my biggest regular complaints in even stocks I own, is of how pump ("going to the moon" etc) will get far more praise on HC than decent analysis. My comment was not embarrassing, just simple direct refute of your unfounded criticism that a clearly extensive posting history across so many stocks (including owning and even shorting larger caps) rather refutes.

Getting back to the company at hand, rather than your personal attacks, well done. You found a stock in the toilet on past poor performance, that every OSX holder present and past were acutely aware of before you came along with your two-bit observations on its business prospects. Rather why it now trades at $4 million valuation, versus the far higher valuation it did in the past.

You know better of course, the poor future business prospects of OSX, as opposed to RxCell, CytoMed, SingHealth, MedSite, A*Star, various universities, and of course Zimmer Biomet, all of whom have recently signed or expanded on collaborating partnerships or distribution deals with it.

Lets hope you are shorting, or even better shorting it from $0.80 (in older pre-consolidation money) in your wisdom, given you know better than them, and investors, recent at these lowly valuations or otherwise, that its probable forward value is more likely zero than higher than $4 mill.